Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-6-20
pubmed:abstractText
Mono ADP-ribosyltransferase 2 (ART2) is an ectoenzyme expressed on mouse T lymphocytes, which catalyze the transfer of ADP-ribose groups from NAD(+) onto several target proteins. In vitro, ADP-ribosylation by ART2 activates the P2X7 ATP receptor and is responsible for NAD(+)-induced T cell death (NICD). Yet, the origin of extracellular NAD(+) and the role of NICD in vivo remain elusive. In a model of acute inflammation induced by polyacrylamide beads, we demonstrate release of NAD(+) into exudates during the early phase of the inflammatory response. This leads to T cell depletion in the draining lymph nodes from wild-type and, more severely, from mice lacking the CD38 NAD(+) glycohydrolase, whereas no effect is observed in ART2-deficient animals. Intravenous injection of NAD(+) used to exacerbate NICD in vivo results in fast and dramatic ART2- and P2X7-dependent depletion of CD4+ and CD8+ T lymphocytes, which can affect up to 80% of peripheral T cells in CD38(-/-) mice. This affects mainly naive T cells as most cells surviving in vivo NAD+ treatment exhibit the phenotype of recently activated/memory cells. Consistently, treatment with NAD(+) abolishes primary Ab response to a T-dependent Ag in NICD-susceptible CD38(-/-) mice but has no effect on the secondary response when given several days after priming. Unexpectedly NAD+ treatment improves the response in their wild-type BALB/c counterparts. We propose that NAD(+) released during early inflammation facilitates the expansion of primed T cells, through ART2-driven death of resting cells, thus contributing to the dynamic regulation of T cell homeostasis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
179
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
186-94
pubmed:dateRevised
2009-9-4
pubmed:meshHeading
pubmed-meshheading:17579037-ADP Ribose Transferases, pubmed-meshheading:17579037-Acute Disease, pubmed-meshheading:17579037-Animals, pubmed-meshheading:17579037-Apoptosis, pubmed-meshheading:17579037-Cell Death, pubmed-meshheading:17579037-G0 Phase, pubmed-meshheading:17579037-Homeostasis, pubmed-meshheading:17579037-Immunologic Memory, pubmed-meshheading:17579037-Immunophenotyping, pubmed-meshheading:17579037-Inflammation Mediators, pubmed-meshheading:17579037-Injections, Intravenous, pubmed-meshheading:17579037-Lymphocyte Activation, pubmed-meshheading:17579037-Lymphocyte Depletion, pubmed-meshheading:17579037-Mice, pubmed-meshheading:17579037-Mice, Inbred BALB C, pubmed-meshheading:17579037-Mice, Knockout, pubmed-meshheading:17579037-NAD, pubmed-meshheading:17579037-Oxidation-Reduction, pubmed-meshheading:17579037-T-Lymphocyte Subsets
pubmed:year
2007
pubmed:articleTitle
NAD+ released during inflammation participates in T cell homeostasis by inducing ART2-mediated death of naive T cells in vivo.
pubmed:affiliation
University Denis Diderot-Paris 7, EA 1556 Paris, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't